New Year, Cosmetic Surgery Predictions

New Year and new predictions for cosmetic surgery in 2009. The American Society for Aesthetic Plastic Surgery (ASAPS) which provides board certification for plastic surgeons in the US, has again given us their predictions for cosmetic procedures in 2009.

The first prediction is that aesthetic cosmetic surgery will continue to increase in popularity across an ever wider spectrum of the population as surgeons continue to develop procedures to cater to many more procedure candidates.

Interest in cosmetic fillers such as Restylane, Juvederm, and Evolence will carry on growing as new products come to market and continue to evolve.

Unfortunately our population is becoming heavier as we get larger. Increasingly though we are realising the negative effects of obesity, leading to a greater number of patients seeking procedures for body shaping after weight loss. It is expected that procedures such as lower body lifts, abdominoplasty, and upper arm lifts will increase over 2009.

It is predicted that Reloxin will gain FDA approval in 2009, possibly leading to approval other countries as a consequence. This will lead to it competing with the extremely popular Botox procedure. Expect to see similar products enter clinical trials as this valuable sector of the cosmetic surgery market continues to grow throughout 2009.

Sadly it is predicted that there will be further horror stories from patients who have tried to cut corners and gone offshore to find either surgery or injectables at discount prices. Hopefully there will be an increase in that availability of good information for procedure candidates helping them to avoid bad choices.

Fat removal by non invasive methods is likely to become a massive cosmetic surgery market in the future, expect therefore to see continued clinical trials in this segment. It is likely that methods such as Ultrashape and SonosSculpt will become a future alternative to liposuction and smart lipo.

We will have more predictions for 2009 from the ASAPS tomorrow so head back over to see what else we are likely to see in cosmetic surgery this year.